The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global On-body Injectors Market Research Report 2025
Synopsis
On-body injectors, also known as on-body delivery systems (OBDS), are medical devices designed to deliver a controlled dose of medication or therapeutic substances subcutaneously (under the skin) over a specified period. These devices are typically worn on the body and are used to administer various treatments, including medications, hormones, and biologics. On-body injectors offer several advantages, including increased patient convenience, improved medication adherence, and the ability to deliver complex therapies.
The scope of this report is non-insulin On-body injectors.
The global On-body Injectors market was valued at US$ 144 million in 2023 and is anticipated to reach US$ 358.5 million by 2030, witnessing a CAGR of 15.0% during the forecast period 2024-2030.
In the global market, On-body Injectors is dominated by core players such as AWest Pharmaceutical Services, Insulet, Gerresheimer, ect. The top three players within this industry account for about 80% of the market share. North America, Europe, and Asia-Pacific are the major manufacturing regions for this product, and they all hold about 15% of the global market share. The product can be categorised on the basis of product type into electronic syringes and mechanical syringes. The product is widely used in the treatment of oncology immunology, cardiovascular diseases, neurological disorders, and other diseases.
This report aims to provide a comprehensive presentation of the global market for On-body Injectors, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding On-body Injectors.
Report Scope
The On-body Injectors market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global On-body Injectors market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the On-body Injectors manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
West Pharmaceutical Services
Insulet
Gerresheimer
United Therapeutics
CC Bio
BD
Ypsomed
Enable Injections
Nemera
Stevanato Group
Sonceboz
Lohmann Therapie-Systeme
Elcam Drug Delivery Devices (E3D)
Segment by Type
Electronic Injectors
Mechanical Injectors
Segment by Application
Immuno-oncology
Cardiovascular Diseases
Neurological Diseases
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of On-body Injectors manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of On-body Injectors in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
On-body injectors, also known as on-body delivery systems (OBDS), are medical devices designed to deliver a controlled dose of medication or therapeutic substances subcutaneously (under the skin) over a specified period. These devices are typically worn on the body and are used to administer various treatments, including medications, hormones, and biologics. On-body injectors offer several advantages, including increased patient convenience, improved medication adherence, and the ability to deliver complex therapies.
The scope of this report is non-insulin On-body injectors.
The global On-body Injectors market was valued at US$ 144 million in 2023 and is anticipated to reach US$ 358.5 million by 2030, witnessing a CAGR of 15.0% during the forecast period 2024-2030.
In the global market, On-body Injectors is dominated by core players such as AWest Pharmaceutical Services, Insulet, Gerresheimer, ect. The top three players within this industry account for about 80% of the market share. North America, Europe, and Asia-Pacific are the major manufacturing regions for this product, and they all hold about 15% of the global market share. The product can be categorised on the basis of product type into electronic syringes and mechanical syringes. The product is widely used in the treatment of oncology immunology, cardiovascular diseases, neurological disorders, and other diseases.
This report aims to provide a comprehensive presentation of the global market for On-body Injectors, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding On-body Injectors.
Report Scope
The On-body Injectors market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global On-body Injectors market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the On-body Injectors manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
West Pharmaceutical Services
Insulet
Gerresheimer
United Therapeutics
CC Bio
BD
Ypsomed
Enable Injections
Nemera
Stevanato Group
Sonceboz
Lohmann Therapie-Systeme
Elcam Drug Delivery Devices (E3D)
Segment by Type
Electronic Injectors
Mechanical Injectors
Segment by Application
Immuno-oncology
Cardiovascular Diseases
Neurological Diseases
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of On-body Injectors manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of On-body Injectors in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 On-body Injectors Market Overview
1.1 Product Overview and Scope of On-body Injectors
1.2 On-body Injectors Segment by Type
1.2.1 Global On-body Injectors Market Value Comparison by Type (2024-2030)
1.2.2 Electronic Injectors
1.2.3 Mechanical Injectors
1.3 On-body Injectors Segment by Application
1.3.1 Global On-body Injectors Market Value by Application: (2024-2030)
1.3.2 Immuno-oncology
1.3.3 Cardiovascular Diseases
1.3.4 Neurological Diseases
1.3.5 Others
1.4 Global On-body Injectors Market Size Estimates and Forecasts
1.4.1 Global On-body Injectors Revenue 2019-2030
1.4.2 Global On-body Injectors Sales 2019-2030
1.4.3 Global On-body Injectors Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 On-body Injectors Market Competition by Manufacturers
2.1 Global On-body Injectors Sales Market Share by Manufacturers (2019-2024)
2.2 Global On-body Injectors Revenue Market Share by Manufacturers (2019-2024)
2.3 Global On-body Injectors Average Price by Manufacturers (2019-2024)
2.4 Global On-body Injectors Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of On-body Injectors, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of On-body Injectors, Product Type & Application
2.7 On-body Injectors Market Competitive Situation and Trends
2.7.1 On-body Injectors Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest On-body Injectors Players Market Share by Revenue
2.7.3 Global On-body Injectors Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 On-body Injectors Retrospective Market Scenario by Region
3.1 Global On-body Injectors Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global On-body Injectors Global On-body Injectors Sales by Region: 2019-2030
3.2.1 Global On-body Injectors Sales by Region: 2019-2024
3.2.2 Global On-body Injectors Sales by Region: 2025-2030
3.3 Global On-body Injectors Global On-body Injectors Revenue by Region: 2019-2030
3.3.1 Global On-body Injectors Revenue by Region: 2019-2024
3.3.2 Global On-body Injectors Revenue by Region: 2025-2030
3.4 North America On-body Injectors Market Facts & Figures by Country
3.4.1 North America On-body Injectors Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America On-body Injectors Sales by Country (2019-2030)
3.4.3 North America On-body Injectors Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe On-body Injectors Market Facts & Figures by Country
3.5.1 Europe On-body Injectors Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe On-body Injectors Sales by Country (2019-2030)
3.5.3 Europe On-body Injectors Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific On-body Injectors Market Facts & Figures by Country
3.6.1 Asia Pacific On-body Injectors Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific On-body Injectors Sales by Country (2019-2030)
3.6.3 Asia Pacific On-body Injectors Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America On-body Injectors Market Facts & Figures by Country
3.7.1 Latin America On-body Injectors Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America On-body Injectors Sales by Country (2019-2030)
3.7.3 Latin America On-body Injectors Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa On-body Injectors Market Facts & Figures by Country
3.8.1 Middle East and Africa On-body Injectors Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa On-body Injectors Sales by Country (2019-2030)
3.8.3 Middle East and Africa On-body Injectors Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global On-body Injectors Sales by Type (2019-2030)
4.1.1 Global On-body Injectors Sales by Type (2019-2024)
4.1.2 Global On-body Injectors Sales by Type (2025-2030)
4.1.3 Global On-body Injectors Sales Market Share by Type (2019-2030)
4.2 Global On-body Injectors Revenue by Type (2019-2030)
4.2.1 Global On-body Injectors Revenue by Type (2019-2024)
4.2.2 Global On-body Injectors Revenue by Type (2025-2030)
4.2.3 Global On-body Injectors Revenue Market Share by Type (2019-2030)
4.3 Global On-body Injectors Price by Type (2019-2030)
5 Segment by Application
5.1 Global On-body Injectors Sales by Application (2019-2030)
5.1.1 Global On-body Injectors Sales by Application (2019-2024)
5.1.2 Global On-body Injectors Sales by Application (2025-2030)
5.1.3 Global On-body Injectors Sales Market Share by Application (2019-2030)
5.2 Global On-body Injectors Revenue by Application (2019-2030)
5.2.1 Global On-body Injectors Revenue by Application (2019-2024)
5.2.2 Global On-body Injectors Revenue by Application (2025-2030)
5.2.3 Global On-body Injectors Revenue Market Share by Application (2019-2030)
5.3 Global On-body Injectors Price by Application (2019-2030)
6 Key Companies Profiled
6.1 West Pharmaceutical Services
6.1.1 West Pharmaceutical Services Corporation Information
6.1.2 West Pharmaceutical Services Description and Business Overview
6.1.3 West Pharmaceutical Services On-body Injectors Sales, Revenue and Gross Margin (2019-2024)
6.1.4 West Pharmaceutical Services On-body Injectors Product Portfolio
6.1.5 West Pharmaceutical Services Recent Developments/Updates
6.2 Insulet
6.2.1 Insulet Corporation Information
6.2.2 Insulet Description and Business Overview
6.2.3 Insulet On-body Injectors Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Insulet On-body Injectors Product Portfolio
6.2.5 Insulet Recent Developments/Updates
6.3 Gerresheimer
6.3.1 Gerresheimer Corporation Information
6.3.2 Gerresheimer Description and Business Overview
6.3.3 Gerresheimer On-body Injectors Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Gerresheimer On-body Injectors Product Portfolio
6.3.5 Gerresheimer Recent Developments/Updates
6.4 United Therapeutics
6.4.1 United Therapeutics Corporation Information
6.4.2 United Therapeutics Description and Business Overview
6.4.3 United Therapeutics On-body Injectors Sales, Revenue and Gross Margin (2019-2024)
6.4.4 United Therapeutics On-body Injectors Product Portfolio
6.4.5 United Therapeutics Recent Developments/Updates
6.5 CC Bio
6.5.1 CC Bio Corporation Information
6.5.2 CC Bio Description and Business Overview
6.5.3 CC Bio On-body Injectors Sales, Revenue and Gross Margin (2019-2024)
6.5.4 CC Bio On-body Injectors Product Portfolio
6.5.5 CC Bio Recent Developments/Updates
6.6 BD
6.6.1 BD Corporation Information
6.6.2 BD Description and Business Overview
6.6.3 BD On-body Injectors Sales, Revenue and Gross Margin (2019-2024)
6.6.4 BD On-body Injectors Product Portfolio
6.6.5 BD Recent Developments/Updates
6.7 Ypsomed
6.6.1 Ypsomed Corporation Information
6.6.2 Ypsomed Description and Business Overview
6.6.3 Ypsomed On-body Injectors Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Ypsomed On-body Injectors Product Portfolio
6.7.5 Ypsomed Recent Developments/Updates
6.8 Enable Injections
6.8.1 Enable Injections Corporation Information
6.8.2 Enable Injections Description and Business Overview
6.8.3 Enable Injections On-body Injectors Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Enable Injections On-body Injectors Product Portfolio
6.8.5 Enable Injections Recent Developments/Updates
6.9 Nemera
6.9.1 Nemera Corporation Information
6.9.2 Nemera Description and Business Overview
6.9.3 Nemera On-body Injectors Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Nemera On-body Injectors Product Portfolio
6.9.5 Nemera Recent Developments/Updates
6.10 Stevanato Group
6.10.1 Stevanato Group Corporation Information
6.10.2 Stevanato Group Description and Business Overview
6.10.3 Stevanato Group On-body Injectors Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Stevanato Group On-body Injectors Product Portfolio
6.10.5 Stevanato Group Recent Developments/Updates
6.11 Sonceboz
6.11.1 Sonceboz Corporation Information
6.11.2 Sonceboz On-body Injectors Description and Business Overview
6.11.3 Sonceboz On-body Injectors Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Sonceboz On-body Injectors Product Portfolio
6.11.5 Sonceboz Recent Developments/Updates
6.12 Lohmann Therapie-Systeme
6.12.1 Lohmann Therapie-Systeme Corporation Information
6.12.2 Lohmann Therapie-Systeme On-body Injectors Description and Business Overview
6.12.3 Lohmann Therapie-Systeme On-body Injectors Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Lohmann Therapie-Systeme On-body Injectors Product Portfolio
6.12.5 Lohmann Therapie-Systeme Recent Developments/Updates
6.13 Elcam Drug Delivery Devices (E3D)
6.13.1 Elcam Drug Delivery Devices (E3D) Corporation Information
6.13.2 Elcam Drug Delivery Devices (E3D) On-body Injectors Description and Business Overview
6.13.3 Elcam Drug Delivery Devices (E3D) On-body Injectors Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Elcam Drug Delivery Devices (E3D) On-body Injectors Product Portfolio
6.13.5 Elcam Drug Delivery Devices (E3D) Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 On-body Injectors Industry Chain Analysis
7.2 On-body Injectors Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 On-body Injectors Production Mode & Process
7.4 On-body Injectors Sales and Marketing
7.4.1 On-body Injectors Sales Channels
7.4.2 On-body Injectors Distributors
7.5 On-body Injectors Customers
8 On-body Injectors Market Dynamics
8.1 On-body Injectors Industry Trends
8.2 On-body Injectors Market Drivers
8.3 On-body Injectors Market Challenges
8.4 On-body Injectors Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
